Aquestive therapeutics reports first quarter 2022 financial results and provides business update

Warren, n.j., may 03, 2022 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today reported financial results for the first quarter ended march 31, 2022 and provided an update on recent developments in its business.
AQST Ratings Summary
AQST Quant Ranking